MMJ International Holdings Corp.

MMJ International Holdings Corp., along with its subsidiary companies, is dedicated to advancing the sciences involving patient use of medical Cannabis. The MMJIH family consists of MMJ Technologies, Inc, MMJ Genomics, Inc., MMJ Health Care, Inc., MMJ Curriculum Inc., and MMJ Cultivation, Inc.

According to the American Medical Association and the American Academy of Family Practice, current methods to assess the nation’s largest and most expensive medical conditions are subjective and ineffective.
The MMJ® family has a better way, utilizing predictive analysis of genetics and other patient factors.
It is our mission to provide patients better information for better health while treating with medical cannabis, from our family to yours.

MMJ Mission and Values

Our mission is to improve the lives of patients

MMJ International Holdings aims to advance the science of medical cannabis through the establishment and operation of patient-focused business entities. We have seized the opportunity to take a scientific approach to proving the efficacy of cannabis as a medicine. This has enabled us to take advantage of cutting-edge technologies and ground-breaking opportunities available in the medical cannabis industry.
Our efforts in the United States, Canada, and Internationally, for the foreseeable future, will revolve around establishing patient clinical trial services within medical markets that can prove the efficacy of medical products being used and developed for treatment of several chronic illnesses. These proprietary extracts are already showing significant anecdotal evidence in several thousand patients currently under a treatment regime.

A genomic computational research center located in Buffalo, NY (BIG).

MMJ Curriculum, Inc.

Without endocannabinology, diagnostics lack important information. We are developing the curriculum for doctors, nurses and healthcare professionals. The lack of knowledge about this area of medicine has led to the inability to treat patients properly. Our curriculum will be incorporated into courses for doctors and nurses with other specialties and will allow for endocannabinology to become a specialty practice. We have a team for getting national accreditation. We will be introducing our curriculums at several universities. After that, we expect all medical professionals to need these courses.
We are also developing CME seminars for national distribution through live and video based content. Our department will be obtaining national and state specific accreditation. We have aligned ourselves with the finest and most knowledgeable doctors and nurses in the world and have the latest information available.

MMJ Genomics, Inc.

Through this subsidiary, the company will collect patient DNA from samples and do genomic research to show how the RNA…

MMJ Technologies, Inc.

Through this subsidiary, the company has developed multiple proprietary Medical Cannabis research technologies to collect …

MMJ Management Team

The company has executed agreements with the several private clinical labs that specialize
in analyzing bio informatics and genomics.

Timothy C. Moynahan

MMJ Chairman

D. Boise

President, CEO

Dr. Brian Mcilroy

Executive Director, Buffalo Institute for Genomics and Data Analytics for UB

Lee Rosebush

Baker Hostetler Advisor

Want to know more about MMJ International Holdings Corp.